NHLBI Funding & Research Opportunities and Announcements for December 8, 2014

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices:

• Request for Comments on the Draft NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research
  (NOT-OD-15-026) Office of the Director, NIH
• Reminder for the Extramural Scientific Community: Implementation of the Genomic Data Sharing Policy Begins January 25, 2015
  (NOT-OD-15-027) Office of the Director, NIH
• Notice of Office of Laboratory Animal Welfare Policy on Shared Animal Welfare Concerns
  (NOT-OD-15-028) Office of the Director, NIH
• NIH Modification to Guidance on Marking Changes in Resubmission Applications
  (NOT-OD-15-030) Office of the Director, NIH
• Update: New Biographical Sketch Format Required for NIH and AHRQ Grant Applications Submitted for Due Dates on or After May 25, 2015
  (NOT-OD-15-032) Office of the Director, NIH
• Notice of NHGRI Participation in PA-14-015 "Ruth L. Kirschstein NRSA Institutional Research Training Grants (Parent T32)" and Establishment of New Training Program in the Ethical, Legal and Social Implications of Genetic and Genomic Research
  (NOT-HG-15-004)
  National Human Genome Research Institute
• Notice of Additional Due Date and Correction for RFA-HG-14-005 "Revisions to Add Biomedical Big Data Training to Active Institutional Training Grants (T32)"
  (NOT-HG-15-009)
  National Human Genome Research Institute
• Notice of Change to Instructions for Senior/Key Personnel in the Overall and Project Components of PAR-13-316 "NHLBI Program Project Applications (P01)"
  (NOT-HL-14-242)
  National Heart, Lung, and Blood Institute
• Request for Information (RFI): Challenges and Opportunities for Exploring and Understanding the Epitranscriptome
  (NOT-RM-15-007)
  NIH Roadmap Initiatives

Requests for Applications: 

• Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator- Directed Therapeutics (R41)
  (RFA-HL-15-026)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): February 9, 2015 and November 9, 2015

• Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator- Directed Therapeutics (R43/R44)
  (RFA-HL-15-027)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): February 9, 2015; November 9, 2015; and November 9, 2016